AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vincristine
Description: Vincristine will be administered IV at a dose of 1.4 mg/m\^2
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Description: Vincristine will be administered IV at a dose of 1.4 mg/m\^2
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Prednisone will be administered orally at a dose of 100 mg/day
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone will be administered orally at a dose of 100 mg/day
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: All participants are required to receive 1000 mg oral paracetamol as premedication prior to starting each infusion of rituximab
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: All participants are required to receive 1000 mg oral paracetamol as premedication prior to starting each infusion of rituximab
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine hydrochloride or alternative antihistamine
Description: All participants are required to receive 50-100 mg oral diphenhydramine hydrochloride or alternative antihistamine as premedication prior to starting each infusion of rituximab
Study NCT04660799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine hydrochloride or alternative antihistamine
Description: All participants are required to receive 50-100 mg oral diphenhydramine hydrochloride or alternative antihistamine as premedication prior to starting each infusion of rituximab
Study NCT05404997 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shockwave Therapy
Description: Subjects in Group A will receive conventional physical therapy treatment that involves lumbar stretching exercises (bridges, knee to chest, press-up back extensions, bird dogs) and core strengthening exercises (partial crunches, pelvic tilts, wall sits, hip stretches) for ten minutes. After the conventional therapy, this group will be given shockwave therapy treatment twice a week for four weeks.~After exposing and cleaning the treated area with alcohol, adequate amount of gel will be placed on the lower back region, and the machine will be adjusted at (2000 shock per session, 8 sessions 2 per week for 4 weeks, energy flux density 0,18mJ per mm square, 2 bars of pressure, frequency 10hz), with using 20mm D-Actor head.
Study NCT05404997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Maitland's lumbar mobilizations
Description: Subjects in Group B will receive conventional physical therapy treatment that involves lumbar stretching exercises (bridges, knee to chest, press-up back extensions, bird dogs) and core strengthening exercises (partial crunches, pelvic tilts, wall sits, hip stretches) for ten minutes.~After the conventional treatment, Group B will be given Maitland's lumbar postero-anterior glide mobilizations initiating from Grade 1, with 3-4 sets of oscillations of 40 counts in each set, 2 sets of oscillations will be given below and above the affected joint level.This whole mobilization treatment will also be given twice a week for 10 minutes.
Study NCT05403450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolinapant
Description: Capsule for oral administration
Study NCT05403450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine + Cedazuridine
Description: Tablet for oral administration
Study NCT06120231 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pulse width modulation
Description: Will be stimulating the pedicle screws utilizing three different pulse-width settings, 0.4 milliseconds, 0.2 milliseconds, and 0.05 milliseconds.
Study NCT05515757 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mobile-app based contingency management
Description: We are adapting an evidence-based outpatient mobile-app based CM intervention to the hospital setting for hospitalized patients with stimulant use disorders requiring prolonged hospitalization. Participants will be enrolled into an 8-week mobile-app based contingency management intervention.
Study NCT04894305 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S
Description: Ad26.COV2.S will be administered as IM injection.
Study NCT04894305 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Ad26.COV2.S
Description: Ad26.COV2.S will be administered as IM injection.
Study NCT05708638 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual anesthesia induction
Description: In manual anesthesia induction, anesthetic agents are administered at a fixed dose and rate adjusted according to the patient's weight
Study NCT05708638 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anesthesia induction with Target controlled infusions (TCI)
Description: Target controlled infusion (TCI) system aims to reach the theoretically targeted blood or brain concentration of anesthetic agents based on the patient's age, weight, and height, with computer-assisted algorithms.
Study NCT06654960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS9531 injection
Description: HRS9531 injection single dose.
Study NCT06654960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride tablets
Description: Metformin Hydrochloride tablets 500mg.
Study NCT06605742 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consultancy
Description: In the single-blind method, subjects do not know which of the experimental or control groups they were selected and therefore which method was applied to them.The researcher knows the subjects selected for the experimental and control groups, and therefore which method was applied to which subjects
Study NCT06585904 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 1 dose of Beetroot juice intake
Description: The volunteer will ingest 1 dose of beetroot juice containing 400mg of inorganic nitrate for 10 days.
Study NCT06585904 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: The volunteer will perform moderate aerobic exercise for 10 consultative days on a cyclergometer.
Study NCT06605690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib and Letrozole Combined With Anlotinib
Description: Dalpiciclib: 150mg orally, once daily, d1-d21, every 28 days as a cycle (3 weeks / 1 week off) Letrozole: 2.5mg orally once daily (continuous) Anlotinib: 12mg orally, once daily, d1-d14, every 21 days as a cycle (use 2 weeks/stop 1 week). One of the last cycles of the new auxiliary The combination of anlotinib is not included in the treatment regimen to ensure that the time interval between anlotinib withdrawal and surgery is more than 2-3 weeks.
Study NCT06661772 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Vancomycin trough concentration method
Description: A blood sample for VTL was drawn 30 minutes before administration, prior to the fourth dose of vancomycin, under a complete aseptic technique, unless otherwise ordered by the medical team. Vancomycin serum concentrations were measured using a Human vancomycin ELISA Kit.
Study NCT06600763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ice pack
Description: The temperature of the area where the ice pack is applied will be measured at one minute intervals, and when the relevant area reaches a temperature of 13.6 0C, the physician will be informed and the drain removal procedure will be initiated.
Study NCT06600763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: warm gel pad
Description: Gel pads kept at room temperature will be applied to the drain area of the pediatric patient whose surgical drain indication is decided to end, in a sheath designed to wrap around the drain. After waiting for 10 minutes in the application area, the drainage system will be removed by the physician.
Study NCT06592495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Period 1
Description: DWJ1589 or DWC202315
Study NCT06592495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Period 2
Description: DWJ1589 or DWC202315
Study NCT06592495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Period 3
Description: DWJ1589 or DWC202315
Study NCT06592495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Period 4
Description: DWJ1589 or DWC202315
Study NCT06606054 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational and implementation Neurocardiology tool
Description: Sites in this arm will be provided with an educational and implementation Neurocardiology tool aiming to improve adherence to best practice recommendations for secondary stroke prevention of cardioembolic strokes, as defined by the WSO Systematic Review and Synthesis of Global Stroke Guidelines or more recent high-quality evidence published after the last stroke guidelines1.
Study NCT06606054 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No educational or implementation tool will be provided
Description: Participants will be followed for up to 12 months. No educational or interventional tool will be provided to sites in this arm until the follow-up period has ended.
Study NCT04845386 — intervention group
Intervention type: DEVICE
Intervention: TOF Cuff on arm
Description: The TOF Cuff will be installed on one arm in opposite of TOF Scan. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.
Study NCT04845386 — intervention group
Intervention type: DEVICE
Intervention: TOF Cuff on lower leg
Description: The TOF Cuff will be installed on one lower leg. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.
Study NCT04845386 — intervention group
Intervention type: DEVICE
Intervention: TOF Scan on toe
Description: The TOF Scan will be installed on hallux . After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.
Study NCT04845386 — intervention group
Intervention type: DEVICE
Intervention: TOF Scan on adductor pollicis
Description: The TOF Scan will be installed on Thumb. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.
Study NCT04845386 — intervention group
Intervention type: DEVICE
Intervention: TOF Scan on corrugator supercilii
Description: The TOF Scan will be installed on corrugator supercilii. After intubation dose of mivacurium continuous monitoring of neuromuscular block started until complete recovery of neuromuscular block.
Study NCT05325541 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visual Biofeedback Therapy
Description: Visual Biofeedback intervention will be given for 24 sessions, comprising of 45-50 minutes, 3 times/week for the duration of 8 weeks.
Study NCT05325541 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Conventional Balance exercise
Description: Conventional Balance exercises will be given for 24 sessions, comprising of 45-50 minutes, 3 times/week for the duration of 8 weeks.
Study NCT06606535 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: validated questionnaires
Description: Validated questionnaires for climacteric symptoms
Study NCT06606535 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: functional MRI
Description: functional MRI
Study NCT06606535 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Optical Coherent Tomography Angiography
Description: OCT angiography, macular and peripapillary scans
Study NCT06346886 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FAITH! HTN app
Description: Participants will remain in the intervention for 11 weeks. The app-based intervention is a tailored program to promote HTN self-management and knowledge through an 11-module educational video series with a focus on HTN. Participants will also be provided with at home Blood Pressure (BP) monitoring system to allow for self-tracking of BP measurements(automatically synchronized with the app). The app will include pre-post module quizzes, a tracking component for participants to input self-monitored measures (medication adherence, diet, physical activity, etc.). The app sharing board will be a moderated discussion platform and feed for participant interaction by posting healthy lifestyle practices through text, photographs and video to foster discussion on HTN management barriers/facilitators. The project team will post weekly to the sharing board on HTN-related topics to generate discussion among patients.
Study NCT03459729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antitumor B
Description: Study participants will take the natural botanical compound ATB during a short window (seven to 28 days). It will be administered at a dose of 1200 mg three times per day (roughly spaced every 8 hours).
Study NCT06605781 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AR/VR technology-based training
Description: Students will receive AR/VR Technology and OSCE in a Virtual Clinical Environment to learn how to assess and manage patients with auditory hallucination. The course was designed as a diverse and interactive learning experience, integrating a virtual clinical environment for auditory hallucinations with the application of Objective Structured Clinical Examination (OSCE). The practicum lasts approximately 15 days, with 8 hours per day. The teaching activities of the course will be held 5 times on days 4, 6, 8, 10, and 12 of the practicum. Additionally, students will have access to the AR/VR materials for self-practice during the practicum.
Study NCT06605781 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: traditional vedio and discussion group
Description: Students will receive a traditional course on auditory hallucination assessment, which includes watching educational videos and participating in a general discussion group on auditory hallucinations. The practicum lasts approximately 15 days, with 8 hours per day. The teaching activities of the traditional course will be held 5 times on days 4, 6, 8, 10, and 12 of the practicum.
Study NCT06605183 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Community walking program using Nordic walking poles
Description: This is a group, community walking program at local parks using Nordic walking poles. Participants will be encouraged to walk briskly but safely for 60 minutes one time per week with the ultimate goal of using this community walking program to build up their step count to 10,000 steps per day. We do not anticipate that the weekly walk will get them to 10,000 steps but we will use that as a weekly event to drive behavioral change throughout the week.
Study NCT06720545 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: No HGNS therapy (HGNS-off)
Description: Prior to enrollment in this study, participants will have been utilizing HGNS at a therapeutic voltage setting confirmed via overnight sleep study. As part of the trial, they will undergo a study arm that involves turning off HGNS therapy (HGNS-off) for between 2-4 weeks.
Study NCT06734793 — intervention group
Intervention type: DEVICE
Intervention: Wearable stethoscope
Description: The device is a soft, wearable stethoscope designed for continuous, comfortable monitoring of patients for abnormal breath sounds, such as wheezing, which can indicate asthma exacerbations. It automatically detects and diagnoses abnormal breath frequencies, wirelessly transmitting data for analysis. Preliminary materials have shown biocompatibility, ensuring the device is safe for use in children. A key feature is its machine-learning algorithm, which can classify and differentiate normal from abnormal sounds with an expected accuracy above 80%. Initial in vivo tests will compare the device's findings to those of a commercial-grade stethoscope in healthy subjects and individuals with asthma. Breath sound data will be used to improve the detection of wheezing sounds from these continuous recordings based on frequency and amplitude analysis of the recordings.
Study NCT06734793 — intervention group
Intervention type: OTHER
Intervention: Routine Clinical lung Auscultation
Description: The study PI will auscultate the participant's lungs at enrollment to ensure that wheezing is present before beginning the continuous recording of the participant's lung sounds. The PI will assess the participant's respiratory status daily at the start of each breath sound recording session.
Study NCT06747364 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol (Ethanol)
Description: Alcohol will be administered to participants by research staff. In Phase 1, participants will consume alcohol designed to produce a targeted blood alcohol concentration (BAC) of 0.06% using the modified Widmark equation.
Study NCT06742346 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non Tailored Messages
Description: Generic messages promoting a plant-based diet were developed, with each message addressing one of the three most commonly mentioned motives for plant-based eating (Miki et al., 2019; Miki et al., 2020): health motives, environmental motives, and animal welfare motives. All messages were designed to be factual (including science-based statistics), concise (4-5 sentences), relevant to teens (e.g., addressing health concerns like acne), and autonomy-supportive (offering suggestions and tips rather than directives) (Hingle et al., 2013). The messages were intentionally crafted in a neutral linguistic style, avoiding highly emotive language, non-standard syntax, or emojis. These messages are delivered from Monday to Friday for two weeks.
Study NCT06742346 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non Tailored Messages
Description: Generic messages promoting a plant-based diet were developed, with each message addressing one of the three most commonly mentioned motives for plant-based eating (Miki et al., 2019; Miki et al., 2020): health motives, environmental motives, and animal welfare motives. All messages were designed to be factual (including science-based statistics), concise (4-5 sentences), relevant to teens (e.g., addressing health concerns like acne), and autonomy-supportive (offering suggestions and tips rather than directives) (Hingle et al., 2013). The messages were intentionally crafted in a neutral linguistic style, avoiding highly emotive language, non-standard syntax, or emojis. These messages are delivered from Monday to Friday for two weeks.
Study NCT06742346 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Linguistically tailored health messages
Description: Linguistically tailored messages are generated using a Large Language Model. Generic messages promoting a plant-based diet were customized to align with participants' linguistic style, including their preferred choice of words, expressed valence, syntax, and emoji use. These messages are delivered from Monday to Friday for two weeks.
Study NCT06758180 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: verbal basic life support training
Description: Both groups will be given verbal adult basic life support training simultaneously, on a day and time that will not conflict with the students' class schedules. The Adult Basic Life Support Training presentation published by the Ministry of Health in 2021 will be used in the training and will last approximately 40 minutes.~A week after the verbal training, a basic life support application for adults will be held in the Faculty of Medicine Skills Laboratory.
Study NCT06758180 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: verbal basic life support training
Description: Both groups will be given verbal adult basic life support training simultaneously, on a day and time that will not conflict with the students' class schedules. The Adult Basic Life Support Training presentation published by the Ministry of Health in 2021 will be used in the training and will last approximately 40 minutes.~A week after the verbal training, a basic life support application for adults will be held in the Faculty of Medicine Skills Laboratory.
Study NCT06758180 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive game intervention
Description: The interactive game group will be given reinforcement training before the laboratory application. Here, each student will play the game accompanied by a researcher.~Lifesaver is an educational game developed by the Resuscitation Council (UK), offered in English and completely free of charge. The game can be downloaded to computers, phones or tablets from Google Play or the App Store. Lifesaver includes four different interactive video scenarios to help users develop their lifesaving skills. The Harry scenario to be used in this research is based on a real case. In the scenario, Harry, a high school student who has a sudden heart attack while playing football, is given heart massage, CPR and defibrillation by his friends.~The game offers different options at each stage to improve the players' knowledge and skill levels. If a wrong choice is made, the same section is played again until the correct step is performed. The completion time of the game may vary average 15 minutes.
Study NCT06758180 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: video training
Description: One week after all students are given verbal adult basic life support training, a video titled Adult Basic Life Support will be shown to the students in the video training group before the laboratory application. The video will be shown by the researcher using a projector. After the video watching process is completed, each student will apply basic life support on the adult training model in turn and the applications will be evaluated individually. In the video training, the video titled Basic Life Support and AED Use - Adult (TYD), which was published as open access on the 'paramedic online' YouTube channel on May 31, 2023 and prepared in accordance with the 2021 ERC guideline, will be used (Paramedic online, 2023). This video covers the topics of heart massage, artificial respiration and automatic external defibrillator use within the scope of basic life support.
Study NCT06760260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human Derived anti-CI135 CAR-T Injection
Description: Autologous genetically modified anti-CI135 CAR transduced T cells